All In MedTech

Device Trial Radar · NCT07696156

Immersive VR to Reduce Stress, Anxiety, and Pain During PICC/Midline Placement

ESTAR-VR Project: Randomized Controlled Trial on the Impact of Virtual Reality on Reducing Stress, Anxiety, and Pain During Invasive Procedures

Last checked: Nov 19, 2026Latest source record: Jul 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 202 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

202

Planned (sponsor's estimate)

Start

Jan 15, 2027

Primary completion

Jan 12, 2028

Study completion Jan 12, 2029

Sponsor

Lead sponsor
diana garciaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Hospital del Mar Research Institute (IMIM)
First posted
Jul 10, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Supportive care
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Medical and technological advancements allow increasingly complex invasive procedures to be performed on hospitalized patients, improving their survival rates and prognosis. However, these interventions impact physical, emotional, and psychological health. In this scenario, post-hospitalization syndrome (PHS) emerges as a concerning phenomenon characterized by functional, emotional, and social decline after discharge. Invasive procedures such as surgeries or prolonged use of catheters not only compromise physical integrity but also contribute to disorders like anxiety, depression, and post-traumatic stress. In fact, between 20% and 30% of patients admitted to the Intensive Care Unit (ICU) develop symptoms compatible with post-traumatic stress disorder. This underscores the need for a comprehensive approach focused on psychological and social well-being during and after the hospital stay. Despite humanization initiatives, few hospitals successfully implement them due to a lack of objective evaluations and clinical recommendations that justify their necessity. In this regard, venous catheterization (VC) is the most prevalent invasive procedure. The pain, anxiety, or fear caused by this technique triggers physiological and psychological alterations that can interfere with the successful insertion of the device. This stress response induces vasoconstriction, reducing the caliber of the vein, which increases technical difficulty, elevates the risk of complications, raises healthcare costs, and negatively impacts patient satisfaction. Natural outdoor environments have been shown to reduce stress, enhancing well-being and health in the general population. In this sense, the use of immersive virtual reality (IVR) to achieve immersion in virtual nature could help not only by diverting attention away from the painful or anxiety-inducing stimulus during invasive procedures but also by providing pleasant stimuli that could have a physiological impact. The objective of this study is to evaluate the impact of IVR on stress and anxiety during VC using validated clinical scales, measuring the caliber of the vessel to be punctured, and determining salivary biomarkers of stress, well-being, and pain. Confirming this hypothesis will provide the evidence to integrate virtual reality into the National Health System as a standard tool for more humanized and innovative care.

Conditions

  • Vasoconstriction
  • Biomarkers
  • Central Venous Catheters
  • Midline Catheter
  • Pain
  • Anxiety
  • Catheterization
  • Peripheral Venous Catheterization
  • Stress (Psychology)

Interventions

  • Immersive Virtual RealityOther

    The intervention consists of an immersive virtual reality (IVR) software designed to provide continuous non-pharmacological distraction during vascular access. Patients can choose from three distinct natural theme environments: 1) Sensory Forest with views of hot air balloons; 2) Sunrises, Sunsets, and Night Sky / Aurora Borealis; and 3) Underwater Experience. The content is delivered via standalone VR headsets. The experience is administered continuously from prior to the sterile field preparation until the end of the PICC or Midline catheter insertion, adjusting its duration to the length of the procedure.

  • Peripherally Inserted Central Catheter (PICC)Device

    Placement of a Peripherally Inserted Central Catheter (PICC) or a Midline catheter made of polyurethane, depending on the patient's clinical indication and venous capital. The procedure is performed by trained vascular access nurses using ultrasound guidance for vein selection and puncture (typically the basilic or brachial vein). The catheter insertion follows the Modified Seldinger Technique under strict sterile conditions. The device may have single, double, or triple lumens, with a caliber ranging from 3Fr to 5Fr. For PICC lines, the correct tip position in the lower third of the superior vena cava is verified using intracavitary ECG or post-procedure chest X-ray.

  • Mepivacaine 2% InjectionDrug

    Subcutaneous local anesthetic administered at the puncture site prior to vein needle insertion to minimize procedural pain

  • Chlorhexidine Gluconate 2%Drug

    Topical antiseptic agent applied to the skin at the insertion site for preoperative skin preparation and antisepsis

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Self-Reported Procedural Anxiety LevelTime frame: Baseline (Day 1, prior to catheter insertion), Periprocedural (Day 1, pre-puncture), and Day 1 (immediately upon completion of the implantation).

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Hospital del Mar

    Barcelona, Barcelona, Spain

  • Hospital del Mar

    Barcelona, Barcelona, Spain

  • Fundació Althaia

    Manresa, Barcelona, Spain

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.